Press Releases
Search
-
28 Nov 2005
E. coli O157: bioMérieux offers food processing industries fast, reliable detection, using VIDAS® ECO and VIDAS ICE tests
Marcy l'Etoile, France - November 28, 2005. E.coli O157 represents a major risk for consumers. It is the main cause of hemolytic uremic syndrome (HUS) that leads to acute renal failure in children. Th...
-
20 Oct 2005
Nine-Month Sales Up 5%
Marcy l'Etoile, France - October 20, 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its nine-month 2005 sales.
-
13 Oct 2005
bioMérieux and ExonHit Therapeutics Extend their Strategic Collaboration
Marcy l'Etoile and Paris, France - October 13, 2005. bioMérieux and ExonHit announced today that they signed an agreement to extend their collaboration for six years for the discovery and development ...
-
01 Oct 2005
bioMérieux Announces 23% Increase in First-Half 2004 Operating Income and Net Income
Marcy l'Etoile, France - October 1st, 2004. bioMérieux, a global leader in the field of in vitro diagnostics, today announces a significant increase in its financial results for the six months ended J...
-
27 Jul 2005
DiagnoSwiss and bioMérieux announce that they have signed an exclusive license agreement for the development and use of DiagnoSwiss electrochemical microchips in human in vitro diagnostics
Marcy l’Etoile - July 27, 2005. Monthey (Switzerland) – Marcy l’Etoile (France), July 27, 2005 – bioMérieux and DiagnoSwiss announced today that DiagnoSwiss has granted bioMérieux with an exclusive wo...
-
20 Jul 2005
First half 2005 sales up 4.0%, second quarter up 7.8%, excluding the currency effect
Marcy l'Etoile, France - 20 July 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its first-half 2005 sales.